Year: 2019

Not for distribution to U.S. news wire services or dissemination in the United States.MISSISSAUGA, Ontario, Dec. 04, 2019 (GLOBE NEWSWIRE) — Wajax Corporation (“Wajax” or the “Corporation”) (TSX: WJX) today announced that it has closed its previously announced public offering of $50 million principal amount of listed senior unsecured debentures, at a price of $1,000 per debenture (the “Debentures”). A syndicate led by BMO Capital Markets, RBC Capital Markets, and Scotia Capital and including TD Securities, CIBC Capital Markets, National Bank Financial, Desjardins Securities and Raymond James acted as underwriters for the offering. The Debentures have an interest rate of 6.00% per annum, payable semi-annually on January 15th and July 15th commencing on July 15, 2020 and will mature on January 15, 2025. The Debentures will commence...

F-Secure Corporation, Press Release, 4 December 2019 at 15.30 EETF-Secure has completed restructuringF-Secure has completed restructuring of operations as planned. The restructuring was estimated to result in annual cost savings of more than EUR 5 million to be achieved by the end of 2020 as originally announced on 7 October 2019. Restructuring included personnel reduction negotiations that resulted in reduction of approximately 60 full-time equivalents globally out of which approximately 25 from Finland.The restructuring enabled F-Secure to capture synergies from acquisition of MWR InfoSecurity, reallocate resources for further growth and streamline common functions. The planned personnel reductions were estimated to be maximum 90 employees globally and 50 employees in Finland. Contact informationEriikka Söderström, CFO, F-Secure+358 44...

F-Secure Oyj, Lehdistötiedote, 4.12.2019, klo 15.30F-Securen uudelleenjärjestely päättynytF-Secure on saanut päätökseen toimintojensa uudelleenjärjestelyn suunnitellusti. Uudelleenjärjestelyn arvioitiin johtavan yli 5 miljoonan euron vuosittaisten kustannussäästöjen saavuttamiseen vuoden 2020 loppuun mennessä, kuten asiasta 7.10.2019 tiedotettiin. Uudelleenjärjestelyyn liittyneet henkilöstön vähentämistä koskevat neuvottelut johtivat globaalisti noin 60 työtehtävän vähennykseen, joista 25 työtehtävää vähennettiin Suomesta.Uudelleenjärjestelyn avulla F-Secure toteutti MWR InfoSecurityn yritysoston synergioita, kohdensi resursseja uudelleen kasvun tukemiseksi ja tehosti tukitoimintoja. Suunniteltujen henkilöstövähennysten arvioitiin olevan enintään 90 työntekijää globaalisti ja enintään 50 työntekijää Suomessa. YhteystiedotEriikka Söderström, Talousjohtaja, F-Secure...

MONTREAL, Dec. 04, 2019 (GLOBE NEWSWIRE) — TELUS Health today announced plans for the national expansion of its LivingWell Companion personal emergency response service (PERS) to support more aging Canadians across the country. Through the acquisition of DirectAlert, a Quebec-based, bilingual PERS company with more than 15 years of experience providing emergency response across Canada, TELUS is now the largest Canadian-owned PERS provider, proudly giving freedom to Canadians who want to live independently at home for longer; while offering peace of mind to their family and loved ones with the assurance of safety and security.DirectAlert will continue providing service under the new DirectAlert by TELUS Health brand into early 2020, ensuring a smooth transition for current customers so they can continue benefiting from the same consistent,...

MONTRÉAL, 04 déc. 2019 (GLOBE NEWSWIRE) — Aujourd’hui, TELUS Santé a annoncé son intention d’offrir son service d’intervention en cas d’urgence Compagnon Santé connectée à plus d’aînés au pays. À la suite de l’acquisition de DirectAlert, une entreprise québécoise qui offre des services d’intervention en cas d’urgence en français et en anglais depuis plus de 15 ans partout au Canada, TELUS devient le plus important fournisseur canadien à permettre aux aînés de demeurer chez eux plus longtemps en leur assurant sécurité et tranquillité d’esprit, ainsi qu’à leur famille.Afin de garantir une transition en douceur, DirectAlert continuera de fournir ses services sous la nouvelle bannière DirectAlert par TELUS Santé jusqu’au début de 2020. Ainsi, les clients continueront de bénéficier du même service d’intervention en cas d’urgence, sans...

ATLANTA, Dec. 04, 2019 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or “Company”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that Rick Eiswirth, President and Chief Executive Officer of Alimera, will be a featured presenter at the LD Micro Main Event on Tuesday, December 10, 2019 at 12:40 PM Pacific Time at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Mr. Eiswirth will provide an overview of the company’s business model and growth strategy and will be available for one-on-one meetings. In addition, his presentation will be webcast. To access the webcast, please visit http://wsw.com/ldmicro17/alim at the time of the presentation. The webcast will also be archived for 90 days and may be subsequently...

LARGO, FL, Dec. 04, 2019 (GLOBE NEWSWIRE) — Stealth Technologies Inc, (OTC PINK: STTH), a company engaged in the business of identifying and capitalizing on emerging technology and associated markets, is pleased to announce that through its previously announced DRTV relationship with Edison Nation, Inc. (EDNT) the Company will bring to market a new product under the WOWFIXIT brand.WOWFIXIT forms an invisible protective layer on all your smartphones and tablets. How does the WOWFIXIT liquid screen protector work? The titanium crystal structure created by WOWFIXIT becomes part of your phone’s display and strengthens it to 9H hardness resulting in a 60% more resistant surface. The nanoparticles are arranged into a structure similar to a crystal lattice where the chemical bond between molecules is very strong. This produces a structure...

UPM-Kymmene Corporation Stock Exchange Release (Flagging Release) 4 December 2019 at 15:00 EETBlackRock’s indirect shareholding in UPM has gone above the threshold of 5 per centUPM-Kymmene Corporation has on 4 December 2019 received an announcement under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.’s indirect shareholding of UPM shares and voting rights has gone above the threshold of 5 per cent on 3 December 2019.According to the announcement, BlackRock, Inc.’s indirect shareholding in UPM has increased to 26,763,000 shares, corresponding to 5.01 per cent of UPM shares and voting rights. The total number of UPM shares and voting rights owned directly or through financial instruments by BlackRock, Inc. and its funds was 5.21 per cent on 3 December 2019. UPM’s registered total...

UPM-Kymmene Oyj                 Pörssitiedote (Liputusilmoitus)                  4.12.2019 klo 15.00 EETBlackRockin välillinen osakeomistus UPM:stä noussut yli 5 prosentin rajanUPM-Kymmene Oyj on 4.12.2019 vastaanottanut arvopaperimarkkinalain 9 luvun 5 pykälän mukaisen liputusilmoituksen, jonka mukaan BlackRock, Inc:n välillinen osakeomistus UPM:n osakkeista ja äänistä on 3.12.2019 noussut yli 5 prosentin rajan.UPM:n saaman tiedon mukaan BlackRock, Inc:n välillinen osakeomistus UPM:stä on noussut 26 763 000 osakkeeseen, mikä vastaa 5,01 prosenttia UPM:n osake- ja äänimäärästä. BlackRock, Inc:n ja sen rahastojen omistamien UPM:n osakkeiden tai niihin liittyvien rahoitusvälineiden kokonaismäärä 3.12.2019 oli 5,21 prosenttia UPM:n kaikista osakkeista ja äänistä. Ilmoituksen prosenttiosuuksien laskennassa on käytetty UPM:n rekisteröityä...

NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) — Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the 2019 Cross-Border Healthcare Winter Summit on Tuesday, December 10, 2019. The Company will present its corporate overview for 2019 with a special focus on growth opportunities driven by advances in the science of cancer metabolism, recently launched pivotal trial in pancreatic cancer and expanding clinical plans for its lead candidate SM-88 (racemetyrosine) in pancreatic, prostate, sarcoma, breast and hematological cancers.Event: 2019 Cross-Border Healthcare Winter SummitPlace: New York CityPresentation Date: December 10, 2019Presentation Time: 2:00 PM ETThe presentation will be accessible on the events page under...